Terhi Ivanoff

Tenecteplase Efficacy in Patients With Distal Occlusions: Secondary Analysis of the TASTE Randomized Clinical Trial

Vignan Yogendrakumar, Justin YH Phung, Hannah Johns, Leonid Churilov et autres

BACKGROUND: Tenecteplase has been previously evaluated in large- and medium-sized vessel occlusion subgroups, but its effectiveness in more distal occlusions, particularly those involving the distal middle cerebral artery branches or the anterior cerebral artery and posterior cerebral artery territories, and across varying …

au, ca, us, nz, ps, es, tw, fi (code pays fourni par la source)

Thrombolysis With Tenecteplase for Minor Disabling Stroke

Yiran Zhang, Brian Buck, Philip A. Barber, Kausik Chatterjee et autres

Importance: Outcomes following intravenous thrombolysis for minor ischemic stroke may vary based on the presence of disabling deficits. Objective: To determine whether intravenous tenecteplase improves outcomes according to US National Institutes of Health Stroke Scale (NIHSS) score-based definitions of pretreatment disabling deficits. …

ca, gb, au, ie, de, br, at, us (code pays fourni par la source)

Sex Differences in Outcomes After Tenecteplase for Minor Stroke: A Subanalysis of the TEMPO‐2 Trial

Amy Yu, Shabnam Vatanpour, Aravind Ganesh, Thalia S. Field et autres

BACKGROUND: In this subanalysis of the TEMPO-2 (Tenecteplase Versus Standard of Care for Minor Ischaemic Stroke With Proven Occlusion) trial, a randomized clinical trial comparing tenecteplase and nonthrombolytic control in patients with minor stroke and symptomatic intracranial occlusion, we investigated sex differences …

ca, au, gb (code pays fourni par la source)

Tenecteplase versus standard of care for minor ischaemic stroke with proven occlusion (TEMPO-2): a randomised, open label, phase 3 superiority trial

Shelagh B. Coutts, Sandeep Ankolekar, Ramana Appireddy, Juan F. Arenillas et autres

ca, gb, es, au, br, at, ie, fi, sg, nz, de (code pays fourni par la source)